Literature DB >> 9422260

Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.

S J Advani1, S J Chmura, R R Weichselbaum.   

Abstract

Improving local tumor control is a goal of modern radiotherapy that will directly impact a majority of cancer patients. Numerous attempts to develop radiosensitizing agents have, however, met with limited clinical success. Recent advances in gene therapeutic approaches have allowed researchers to combine gene therapy with ionizing radiation to enhance tumor cell killing. In the following review, we discuss the current advances in the use of radiation-inducible promoters, the use of pro-drug converting enzymes, and cytotoxic cytokines to enhance the therapeutic efficacy of ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422260

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  A challenge for high-precision radiation therapy: the case for photons.

Authors:  R A Gahbauer
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer.

Authors:  David P Eisenberg; Prasad S Adusumilli; Karen J Hendershott; Zhenkun Yu; Michael Mullerad; Mei-Ki Chan; Ting-Chao Chou; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

3.  p53 activated by AND gate genetic circuit under radiation and hypoxia for targeted cancer gene therapy.

Authors:  Miao Ding; Rong Li; Rong He; Xingyong Wang; Qijian Yi; Weidong Wang
Journal:  Cancer Sci       Date:  2015-09       Impact factor: 6.716

4.  Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo.

Authors:  Hao Zhang; Chen Liang; Xinxin Hou; Ling Wang; Dongsheng Zhang
Journal:  Int J Nanomedicine       Date:  2016-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.